(ONCT) – SEC Filings
-
Form S-3 Oncternal Therapeutics,
-
Form 10-K Oncternal Therapeutics, For: Dec 31
-
Form 8-K Oncternal Therapeutics, For: Mar 07
-
Form 4 Oncternal Therapeutics, For: Feb 23 Filed by: Wills Robert James
-
Form 4 Oncternal Therapeutics, For: Feb 23 Filed by: HALE DAVID F
-
Form 4 Oncternal Therapeutics, For: Feb 14 Filed by: BREITMEYER JAMES B
-
Form 4 Oncternal Therapeutics, For: Feb 14 Filed by: Yazji Salim
-
Form 4 Oncternal Therapeutics, For: Feb 14 Filed by: VINCENT RICHARD G
-
Form 4 Oncternal Therapeutics, For: Feb 14 Filed by: Leavitt Chase C.
-
Form 4 Oncternal Therapeutics, For: Feb 14 Filed by: Krishnan Rajesh
-
Form SC 13G/A Oncternal Therapeutics, Filed by: VANGUARD GROUP INC
-
Form 8-K Oncternal Therapeutics, For: Jan 22
-
Form 4 Oncternal Therapeutics, For: Jan 03 Filed by: Krishnan Rajesh
-
Form 4 Oncternal Therapeutics, For: Jan 03 Filed by: VINCENT RICHARD G
-
Form 8-K Oncternal Therapeutics, For: Jan 03
-
Form 4 Oncternal Therapeutics, For: Jan 03 Filed by: Yazji Salim
-
Form 4 Oncternal Therapeutics, For: Jan 03 Filed by: Leavitt Chase C.
-
Form 4 Oncternal Therapeutics, For: Jan 03 Filed by: BREITMEYER JAMES B
-
Form 10-Q Oncternal Therapeutics, For: Sep 30
-
Form 8-K Oncternal Therapeutics, For: Nov 09
-
Form 8-K Oncternal Therapeutics, For: Oct 03
-
Form 4 Oncternal Therapeutics, For: Oct 02 Filed by: Leavitt Chase C.
-
Form 4 Oncternal Therapeutics, For: Oct 02 Filed by: Yazji Salim
-
Form 4 Oncternal Therapeutics, For: Oct 02 Filed by: BREITMEYER JAMES B
-
Form 4 Oncternal Therapeutics, For: Oct 02 Filed by: VINCENT RICHARD G
-
Form 4 Oncternal Therapeutics, For: Oct 02 Filed by: Krishnan Rajesh
-
Form 8-K/A Oncternal Therapeutics, For: Jun 28
-
Form 10-Q Oncternal Therapeutics, For: Jun 30
-
Form 8-K Oncternal Therapeutics, For: Aug 10
-
Form 4 Oncternal Therapeutics, For: Jul 03 Filed by: BREITMEYER JAMES B
-
Form 4 Oncternal Therapeutics, For: Jul 03 Filed by: VINCENT RICHARD G
-
Form 4 Oncternal Therapeutics, For: Jul 03 Filed by: Leavitt Chase C.
-
Form 4 Oncternal Therapeutics, For: Jul 03 Filed by: Yazji Salim
-
Form 4 Oncternal Therapeutics, For: Jul 03 Filed by: Krishnan Rajesh
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: LARUE WILLIAM R
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: CARTER MICHAEL G
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: HALE DAVID F
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: Nakanishi Xin
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: MAZANET ROSEMARY
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: THEUER CHARLES
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: KISNER DANIEL L
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: Wills Robert James
-
Form 4 Oncternal Therapeutics, For: Jun 28 Filed by: DeSimone Jill
-
Form 8-K Oncternal Therapeutics, For: Jun 28
-
Form 4 Oncternal Therapeutics, For: Jun 12 Filed by: Kaufmann Gunnar F.
-
Form 8-K Oncternal Therapeutics, For: May 26
-
Form ARS Oncternal Therapeutics, For: Dec 31
-
Form DEFA14A Oncternal Therapeutics,
-
Form DEF 14A Oncternal Therapeutics, For: Jun 28
-
Form PRE 14A Oncternal Therapeutics, For: Jun 28
Back to ONCT Stock Lookup